Nat West Group PLC Gilead Sciences, Inc. Transaction History

Nat West Group PLC

$339 Million
Q1 2025

A detailed history of Nat West Group PLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Nat West Group PLC holds 120,498 shares of GILD stock, worth $13.1 Million. This represents 3.98% of its overall portfolio holdings.

Number of Shares

120,498

Previous 73,702 63.49%

Holding current value

$13.1 Million

Previous $6.81 Million 98.34%

% of portfolio

3.98%

Previous 2.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$89.14 - $117.41 $4.17 Million - $5.49 Million	46,796 Added 63.49%	120,498 $13.5 Million
Q4 2024 Jan 28, 2025	BUY	$83.95 - $97.9 $6.19 Million - $7.22 Million	73,702 New	73,702 $6.81 Million
Q1 2023 Apr 24, 2023	SELL	$77.31 - $88.08 $60,842 - $69,318	-787 Reduced 17.7%	3,660 $303,000
Q4 2022 Jan 27, 2023	SELL	$62.32 - $89.47 $84,692 - $121,589	-1,359 Reduced 23.41%	4,447 $0
Q2 2022 Jul 20, 2022	SELL	$57.72 - $65.01 $202,020 - $227,535	-3,500 Reduced 37.61%	5,806 $359,000
Q3 2021 Oct 26, 2021	SELL	$67.69 - $73.03 $1.66 Million - $1.79 Million	-24,497 Reduced 72.47%	9,306 $650,000
Q2 2021 Jul 21, 2021	BUY	$63.47 - $69.35 $17,771 - $19,418	280 Added 0.84%	33,803 $2.33 Million
Q1 2021 Apr 16, 2021	BUY	$60.0 - $68.46 $8,040 - $9,173	134 Added 0.4%	33,523 $2.17 Million
Q4 2020 Feb 04, 2021	SELL	$56.65 - $64.55 $510,076 - $581,208	-9,004 Reduced 21.24%	33,389 $1.95 Million
Q3 2020 Nov 10, 2020	BUY	$62.1 - $78.08 $339,749 - $427,175	5,471 Added 14.82%	42,393 $2.68 Million
Q2 2020 Jul 16, 2020	BUY	$72.34 - $84.0 $290,879 - $337,764	4,021 Added 12.22%	36,922 $2.84 Million
Q1 2020 May 07, 2020	BUY	$62.63 - $80.22 $264,048 - $338,207	4,216 Added 14.7%	32,901 $2.46 Million
Q4 2019 Feb 06, 2020	BUY	$61.62 - $67.78 $623,163 - $685,459	10,113 Added 54.45%	28,685 $1.86 Million
Q3 2019 Oct 24, 2019	SELL	$62.51 - $69.0 $4,938 - $5,451	-79 Reduced 0.42%	18,572 $1.18 Million
Q2 2019 Jul 25, 2019	BUY	$61.87 - $69.38 $302,853 - $339,615	4,895 Added 35.58%	18,651 $1.26 Million
Q1 2019 May 08, 2019	BUY	$62.53 - $70.05 $73,160 - $81,958	1,170 Added 9.3%	13,756 $895,000
Q4 2018 Feb 12, 2019	BUY	$60.54 - $79.0 $13,379 - $17,459	221 Added 1.79%	12,586 $787,000
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $19.3 Million - $21.4 Million	-271,087 Reduced 95.64%	12,365 $954,000
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $457,858 - $534,073	7,057 Added 2.55%	283,452 $20.1 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $581,117 - $708,446	7,978 Added 2.97%	276,395 $20.8 Million
Q4 2017 Feb 06, 2018	BUY	$71.15 - $83.52 $363,434 - $426,620	5,108 Added 1.94%	268,417 $19.2 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $1.86 Million - $2.21 Million	25,822 Added 10.87%	263,309 $21.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	237,487	237,487 $16.8 Million

Others Institutions Holding GILD

# of Institutions

2,288

Shares Held

997M

Call Options Held

9.62M

Put Options Held

10M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $136B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nat West Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Nat West Group PLC with notifications on news.

Account

Nat West Group PLC Gilead Sciences, Inc. Transaction History